HeartBeam, Inc. (BEATW) — Quarterly Report

Key Insights

• HeartBeam is a smaller reporting company and non-accelerated filer in the medical device sector, trading on NASDAQ under ticker BEAT with warrants (BEATW) also listed, indicating early-stage growth company status with potential liquidity constraints.
• The filing shows multiple equity compensation mechanisms in place including employee stock options, restricted stock units, and public/at-the-market offerings during Q1 2026, suggesting ongoing capital raises and shareholder dilution to fund operations.
• Recent subsequent events noted between April 14-May 11, 2026 indicate active corporate activities post-quarter end, though specific details are truncated in the provided content, warranting review of full filing for material announcements.